Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001665124-26-000008

President and Head of R&D sold 116,050 shares at an average $4.72 ($547,469)

From the SEC's structured data for this filing

Trades in this filing

Nagendran Sukumar · President and Head of R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-23 Sale : show line 1 in the form −89,132 $4.75 $423,377 1,344,307 D
2026-01-26 Sale : show line 2 in the form −26,918 $4.61 $124,092 1,317,389 D
Open-market sales · 116,050 sh · avg $4.72 · $547,469
Loading xslF345X05/form4-01272026_040105.xml…